SLS NASDAQ
SELLAS Life Sciences Group, Inc.
1W: +1.9%
1M: +58.2%
3M: +82.2%
YTD: +73.8%
1Y: +289.7%
3Y: +378.5%
5Y: -7.2%
$7.78
+0.22 (+2.91%)
Weekly Expected Move ±16.8%
$5
$6
$7
$8
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-29M
Net Income
-8.6% YoY
$-28M
Free Cash Flow
+16.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-73.3%
ROA-60.3%
ROIC118360.8%
Valuation
P/E-45.3
P/B12.4
EV/EBITDA-27.7
Leverage
Debt/Equity0.01
Current Ratio10.72
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z53.40
Beneish M0.00